-transparent.png){kind=logo}
The Na+-induced release of accumulated Ca2+ from heart mitochondria is inhibited by amiloride, benzamil and several other amiloride analogues. These drugs do not affect uptake or release of Ca2+ mediated by the ruthenium red-sensitive uniporter and their effects, like those of diltiazem and other Ca2+-antagonists, appear to be localized principally at the Na+/Ca2+ antiporter of the mitochondrion. Benzamil inhibits Na+/Ca2+ antiport non-competitively with respect to [Na+] with a Ki of 167 microM. In the presence of 1.5 mM Pi the Ki for benzamil inhibition of this reaction is decreased to 87 microM.
Related Publications
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
May 1985,
Molecular pharmacology,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
March 2000,
General physiology and biophysics,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
December 1982,
Journal of bioenergetics and biomembranes,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
March 1985,
FEBS letters,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
March 1994,
The American journal of physiology,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
January 1989,
The American journal of physiology,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
March 1985,
Biochemistry,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
March 1979,
The Biochemical journal,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
August 1991,
Naunyn-Schmiedeberg's archives of pharmacology,
M S Jurkowitz, and
R A Altschuld, and
G P Brierley, and
E J Cragoe
October 1985,
Cell calcium,
